In this edition, we explore developments in AI and digital health, cross-border licensing challenges, the pharmaceutical patent cliff, and other key areas.
Welcome to the latest edition of our Healthcare & Life Sciences Market Update, in which we explore the evolving landscape of investment trends, regulatory challenges, and strategic opportunities shaping the global market.
As we enter 2026, we continue to see measured optimism across the industry, fueled by a wave of innovative products, services, and transaction structures entering the market. This optimism, which is rooted in execution, persists despite the array of legal and policy challenges facing healthcare and life sciences companies, investors, and other industry stakeholders.
